血凝块结构:血液透析患者死亡风险的强效独立危险因素
该前瞻性队列纳入171例慢性血液透析患者(平均年龄59±11岁,54%为男性),用经验证的浊度法测定纤维蛋白凝块结构。Kaplan-Meier分析显示凝块结构更致密的患者全因死亡和心血管死亡风险均升高(log rank P=0.004和P=0.003)。多因素Cox回归校正年龄、糖尿病、性别及透析时长或纤维蛋白原、C反应蛋白、补体C3后,证实致密凝块与死亡风险独立相关。
要点
- 血液透析患者中,纤维蛋白凝块结构更致密与全因死亡和心血管死亡风险升高相关。
- 多因素Cox回归校正混杂因素后,致密凝块仍与死亡风险独立相关。
- 患者纯化的纤维蛋白原存在糖基化和胍基化修饰,其形成的凝块纤维更细。
核心结论
- 在血液透析患者中,更致密的凝块结构可能是死亡的强效独立危险因素。
研究设计与样本
- 前瞻性队列研究,纳入171例慢性血液透析患者(平均±标准差年龄59±11岁;54%为男性),使用经验证的浊度法测定纤维蛋白凝块结构参数。
主要发现
- Kaplan-Meier分析显示,凝块结构更致密的血液透析患者全因死亡风险升高(log rank P=0.004),心血管死亡风险亦升高(log rank P=0.003)。
- 多因素Cox回归模型(校正年龄、糖尿病、性别及透析时长,或校正纤维蛋白原、C反应蛋白和补体C3)证实,更致密的凝块与死亡风险独立相关。
- 从健康对照和血液透析患者中用钙依赖性IF-1抗纤维蛋白原单克隆抗体纯化纤维蛋白原:健康对照的纯化纤维蛋白原无翻译后修饰,而血液透析患者的纤维蛋白原发生了糖基化和胍基化修饰。
- 由血液透析患者纯化纤维蛋白原形成的凝块纤维显著细于对照个体纤维蛋白原形成的凝块(平均±标准差分别为63±2 nm和77±2 nm;P<0.001)。
- 健康受试者纤维蛋白原的体外胍基化增加了细纤维的形成,提示纤维粗细差异可能至少部分归因于翻译后修饰。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Patients with CKD on hemodialysis exhibit increased cardiovascular risk. Fibrin clot structure and clot lysis are crucially involved in development of cardiovascular events, but little is known about the influence of clot density on outcome in patients on hemodialysis. We determined fibrin clot structure parameters and effect on mortality in a prospective cohort of 171 patients on chronic hemodialysis (mean±SD age =59±11 years old; 54% men) using a validated turbidimetric assay. Kaplan-Meier analysis revealed that patients on hemodialysis with a denser clot structure had increased all-cause and cardiovascular mortality risks (log rank P=0.004 and P=0.003, respectively). Multivariate Cox regression models (adjusted for age, diabetes, sex, and duration of dialysis or fibrinogen, C-reactive protein, and complement C3) confirmed that denser clots are independently related to mortality risk. We also purified fibrinogen from healthy controls and patients on hemodialysis using the calcium-dependent IF-1 mAb against fibrinogen for additional investigation using mass spectrometric analysis and electron microscopy. Whereas purified fibrinogen from healthy controls displayed no post-translational modifications, fibrinogen from patients on hemodialysis was glycosylated and guanidinylated. Clots made of purified fibrinogen from patients on hemodialysis exhibited significantly thinner fibers compared with clots from fibrinogen of control individuals (mean±SD =63±2 and 77±2 nm, respectively; P<0.001). In vitro guanidinylation of fibrinogen from healthy subjects increased the formation of thinner fibers, suggesting that difference in fiber thickness might be at least partially due to post-translational modifications. Thus, in patients on hemodialysis, a denser clot structure may be a potent independent risk factor for mortality.
引用
- Schuett K, Savvaidis A, Maxeiner S, et al. Clot Structure: A Potent Mortality Risk Factor in Patients on Hemodialysis. J Am Soc Nephrol. 2017. PMID: 28057772. doi:10.1681/ASN.2016030336
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。